24/7 Wall St. on MSN17h
Billionaire Sells Palantir Stock and Buys This Stock That Could Soar 64% According to a Wall Street Expert
Billionaire investor Ken Griffin is the founder of Citadel Advisors, one of the world’s most successful alternative ...
Zacks.com on MSN19h
Denali Gains 26.6% in a Year: How Should You Play the Stock?
Denali Therapeutics DNLI has performed well in the past 12 months amid a volatile market. Shares of the company have gained ...
FiercePharma15h
Sage sues Biogen as analyst detects little interest in buyout at original offer price
Sage Therapeutics has brought a lawsuit against Biogen shortly after receiving an “unsolicited” offer from its neuroscience ...
BioSpace17h
Sage Sues Partner Biogen After Unsolicited Takeover Offer
Biogen’s effort to buy Sage reveals its “desire to expand its pipeline at a discount,” according to analysts from BMO Capital ...
BioWorld7h
Sage lawsuit enforces standstill as board evaluates Biogen offer
A series of disappointments that drove Sage Therapeutics Inc.’s stock down by 85% since August of 2023 has evolved into an unsolicited takeout offer by partner Biogen Inc., followed by a lawsuit filed ...
Solid Biosciences: Differentiating Factors Of SGT-212 To Set Itself Apart
Discover the latest advancements in gene therapy for rare diseases like Friedreich's Ataxia and Duchenne Muscular Dystrophy, ...